Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

First-in-human Phase 1/2 clinical trial of iPSC derived islet-like clusters in combination with Cell Pouch™ device for the treatment of patients with T1D and severe hypoglycemia

Trial Profile

First-in-human Phase 1/2 clinical trial of iPSC derived islet-like clusters in combination with Cell Pouch™ device for the treatment of patients with T1D and severe hypoglycemia

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 20 May 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 14 May 2025 According to a Sernova Corp media release, Clinical trials with iPSC islet-like clusters from Sernova's partner, Evotec, are anticipated to begin in 2026 after completion of Cohort C of the ongoing trial.
  • 11 Oct 2023 Status changed from planning to recruiting.
  • 11 Oct 2023 According to a Sernova Corp media release, new data from this study will be presented at International Pancreas and Islet Transplant Association (IPITA) on Thursday, October 26, 2023

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top